Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MR proton spectroscopy in multiple sclerosis.

R I Grossman1, R E Lenkinski, K N Ramer

  • 1Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia 19104.

AJNR. American Journal of Neuroradiology
|November 1, 1992
PubMed
Summary

Proton spectroscopy reveals distinct biochemical processes in multiple sclerosis lesions. It identifies neuronal loss and ongoing demyelination, offering insights beyond traditional MRI contrast enhancement.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Central vein sign: A diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial.

NeuroImage. Clinical·2021
Same author

Cognitive processing speed in multiple sclerosis clinical practice: association with patient-reported outcomes, employment and magnetic resonance imaging metrics.

European journal of neurology·2020
Same author

Knowledge of radiation legislation and guidelines amongst foundation doctors is inadequate for safe practice in the current era of radiology.

Clinical radiology·2019
Same author

Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS).

Multiple sclerosis and related disorders·2015
Same author

Vocalizations in wild canids and possible effects of domestication.

Behavioural processes·2014
Same author

A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis.

Journal of neurology·2014

Area of Science:

  • Neuroimaging
  • Biochemistry
  • Neurology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • Magnetic Resonance (MR) imaging is crucial for diagnosing and monitoring MS.
  • Proton spectroscopy (1H spectroscopy) offers biochemical insights into brain lesions.

Purpose of the Study:

  • To investigate the natural history of MR abnormalities in MS patients using 1H spectroscopy.
  • To differentiate between various lesion types based on biochemical markers.

Main Methods:

  • 16 patients with clinically definite MS underwent MR imaging and 1H spectroscopy.
  • Gadolinium-diethylenetriaminepentaacetic acid (Gd-DTPA) contrast was administered.
  • Analysis focused on N-acetylaspartate (NAA) levels and specific spectral peaks (marker peaks).

Related Experiment Videos

Main Results:

  • Decreased NAA, indicating neuronal loss, was found in most lesions.
  • Enhancing lesions often showed marker peaks (2.1-2.6 ppm), suggesting demyelination.
  • Unenhancing lesions generally had lower or absent marker peaks.
  • No correlation was observed between NAA levels and marker peaks.

Conclusions:

  • Enhancing lesions with marker peaks likely represent active demyelination.
  • Enhancing lesions without marker peaks may be edematous.
  • 1H spectroscopy can better characterize MS lesions and their duration than contrast enhancement alone.